Surge Therapeutics has raised money to take its extended-release biodegradable hydrogel into the clinic, reeling in $26 million to test its belief that implanting the …
An investigational drug called NXP800, discovered at the Cancer Research UK Cancer Therapeutics Unit at London’s Institute of Cancer Research (ICR), is to enter Phase …
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative
